Anti-infection
-
BA2241 R-10015Summary: R-10015, a broad-spectrum antiviral compound for infections, is a highly potent and selective inhibitor that blocks LIMK by binding to the ATP-binding pocket. - BA2249 AVG-233Summary: AVG-233 is an orally effective RNA-dependent RNA polymerase inhibitor.
- BA2257 GSK3326595Summary: GSK3326595 is a protein arginine methyltransferase 5 inhibitor.
- BA2258 ZotatifinSummary: Zotatifin (eFT226) is a potent, selective and well-tolerated eIF4A inhibitor.
-
BA2262 LP-935509Summary: LP-935509 is an orally potent, selective, ATP-competitive, and blood-brain barrier-crossing inhibitor of junctional protein-2-related kinase 1. - BA2266 EnoxaparinSummary: Enoxaparin (PK10169) is a low molecular heparin (LMWH) derivative.
- BA2271 Vps34-IN-2Summary: Vps34-IN-2 is a novel, potent and selective inhibitor.
-
BA2273 QuipazineSummary: Quipazine is an agonist. - BA2276 ONO-5334Summary: ONO-5334 is a potent, selective and orally active tissue proteinase K inhibitor.
- BA2278 rel-ZotatifinSummary: re-Zotatifin is a racemic isomer of Zotatifin and is less active than Zotatifin as an eIF4A inhibitor.